• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.17% Nasdaq Up 1.27%

    Alkermes plc (ALKS)

    -NasdaqGS
    61.70 Down 1.09(1.74%) Apr 20, 4:00PM EDT
    Add to Portfolio
    Prev Close:62.79
    Open:63.07
    Bid:54.60 x 200
    Ask:65.47 x 100
    1y Target Est:69.82
    Beta:1.47
    Earnings Date:Apr 27 - May 1 (Est.)
    Day's Range:61.11 - 63.09
    52wk Range:38.49 - 75.17
    Volume:621,232
    Avg Vol (3m):1,427,320
    Market Cap:9.14B
    P/E (ttm):N/A
    EPS (ttm):-0.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALKS

    Comparison

    Symbol% ChgMkt Cap
    ALKSDown 1.74%9.14B
    ABT 0.00%70.36B
    LLY 0.00%76.80B
    GSK 0.00%113.30B

    Key Statistics

    Forward P/E (1 yr):3,085.00
    P/S (ttm):15.03
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.39
    Quarterly EPS Est (Mar-15) :-0.03
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-2.44

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes Public Limited Company, an integrated biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback